.png)
Oncology Clinical Trials Market by Phaseand Application- Global Industry Analysis & Forecast to 2027
Published On : October 2020 Pages : 180 Category: Pharma & Healthcare Report Code : HC1013129
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Oncology Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV) and Application (Lung cancer, Breast cancer, Thyroid cancer, Leukemia, Other Cancer)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Oncology Clinical Trials Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Oncology Clinical Trials begins with research in a lab. These clinical trials are performed by doctors,and specifically determine whether new treatments are safe and effective and work better than current treatments and also help to find new ways to prevent and detect cancer.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Oncology Clinical Trials Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- PAREXEL International Corporation
- PRA Health Sciences
- Syneos Health
- Medpace
- Novotech
- Pivotal
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Oncology Clinical Trials Market, ByPhase, Estimates and Forecast, 2017-2027 ($Million)
o Phase I
o Phase II
o Phase III
o Phase IV
· Oncology Clinical Trials Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Lung cancer
o Breast cancer
o Thyroid cancer
o Leukemia
o Other Cancer
· Oncology Clinical Trials Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o PAREXEL International Corporation
o PRA Health Sciences
o Syneos Health
o Medpace
o Novotech
o Pivotal
· Oncology Clinical Trials Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Oncology Clinical Trials Market , By Country
o U.S. Oncology Clinical Trials Market
o Canada Oncology Clinical Trials Market
o Mexico Oncology Clinical Trials Market
o Europe
§ Europe Oncology Clinical Trials Market , By Country
o UK Oncology Clinical Trials Market
o Germany Oncology Clinical Trials Market
o France Oncology Clinical Trials Market
o Russia Oncology Clinical Trials Market
o Italy Oncology Clinical Trials Market
o Rest of Europe Oncology Clinical Trials Market
o Asia-Pacific
§ Asia-Pacific Oncology Clinical Trials Market , By Country
o China Oncology Clinical Trials Market
o Japan Oncology Clinical Trials Market
o South Korea Oncology Clinical Trials Market
o India Oncology Clinical Trials Market
o Southeast Asia Oncology Clinical Trials Market
o Rest of Asia-Pacific Oncology Clinical Trials Market
o South America
§ South America Oncology Clinical Trials Market
o Brazil Oncology Clinical Trials Market
o Argentina Oncology Clinical Trials Market
o Columbia Oncology Clinical Trials Market
o Rest of South America Oncology Clinical Trials Market
o Middle East and Africa
§ Middle East and Africa Oncology Clinical Trials Market
o Saudi Arabia Oncology Clinical Trials Market
o UAE Oncology Clinical Trials Market
o Egypt Oncology Clinical Trials Market
o Nigeria Oncology Clinical Trials Market
o South Africa Oncology Clinical Trials Market
o TurkeyOncology Clinical Trials Market
o Rest of MEA Oncology Clinical Trials Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Oncology Clinical Trials Market, By Phase
5.1. Introduction
5.2. Global Oncology Clinical Trials Revenue and Market Share by Phase (2017-2021)
5.2.1. Global Oncology Clinical Trials Revenue and Revenue Share by Phase (2017-2021)
5.3. Phase I
5.3.1. Global Phase I Revenue and Growth Rate (2017-2021)
5.4. Phase II
5.4.1. Global Phase II Revenue and Growth Rate (2017-2021)
5.5. Phase III
5.5.1. Global Phase III Revenue and Growth Rate (2017-2021)
5.6. Phase IV
5.6.1. Global Phase IV Revenue and Growth Rate (2017-2021)
6. Oncology Clinical Trials Market, By Applications
6.1. Introduction
6.2. Global Oncology Clinical Trials Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Oncology Clinical Trials Revenue and Revenue Share by Applications (2017-2021)
6.3. Lung cancer
6.3.1. Global Lung cancer Revenue and Growth Rate (2017-2021)
6.4. Breast cancer
6.4.1. Global Breast cancer Revenue and Growth Rate (2017-2021)
6.5. Thyroid cancer
6.5.1. Global Thyroid cancer Revenue and Growth Rate (2017-2021)
6.6. leukemia
6.6.1. Global leukemia Revenue and Growth Rate (2017-2021)
6.7. Other Cancer
6.7.1. Global Other Cancer Revenue and Growth Rate (2017-2021)
7. Oncology Clinical Trials Market, By Region
7.1. Introduction
7.2. Global Oncology Clinical Trials Revenue and Market Share by Regions
7.2.1. Global Oncology Clinical Trials Revenue by Regions (2017-2021)
7.3. North America Oncology Clinical Trials by Countries
7.3.1. North America Oncology Clinical Trials Revenue and Growth Rate (2017-2021)
7.3.2. North America Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Oncology Clinical Trials by Countries
7.4.1. Europe Oncology Clinical Trials Revenue and Growth Rate (2017-2021)
7.4.2. Europe Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Oncology Clinical Trials by Countries
7.5.1. Asia-Pacific Oncology Clinical Trials Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Oncology Clinical Trials by Countries
7.6.1. South America Oncology Clinical Trials Revenue and Growth Rate (2017-2021)
7.6.2. South America Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Oncology Clinical Trials by Countries
7.7.1. Middle East and Africa Oncology Clinical Trials Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. PAREXEL International Corporation
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. PRA Health Sciences
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Syneos Health
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Medpace
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Novotech
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Pivotal
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
9. Oncology Clinical Trials Market Forecast (2022-2027)
9.1. Global Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Oncology Clinical Trials Market Forecast by Regions (2022-2027)
9.2.1. North America Oncology Clinical Trials Market Forecast (2022-2027)
9.2.1.1. United States Oncology Clinical Trials Market Forecast (2022-2027)
9.2.1.2. Canada Oncology Clinical Trials Market Forecast (2022-2027)
9.2.1.3. Mexico Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2. Europe Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.1. Germany Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.2. France Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.3. UK Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.4. Russia Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.5. Italy Oncology Clinical Trials Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3. Asia-Pacific Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.1. China Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.2. Japan Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.3. Korea Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.4. India Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Oncology Clinical Trials Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Oncology Clinical Trials Market Forecast (2022-2027)
9.2.4. South America Oncology Clinical Trials Market Forecast (2022-2027)
9.2.4.1. Brazil Oncology Clinical Trials Market Forecast (2022-2027)
9.2.4.2. Argentina Oncology Clinical Trials Market Forecast (2022-2027)
9.2.4.3. Columbia Oncology Clinical Trials Market Forecast (2022-2027)
9.2.4.4. Rest of South America Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5. Middle East and Africa Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.3. Egypt Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.4. Nigeria Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.5. South Africa Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.6. Turkey Oncology Clinical Trials Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Oncology Clinical Trials Market Forecast (2022-2027)
9.3. Oncology Clinical Trials Market Forecast by Phase (2022-2027)
9.3.1. Oncology Clinical Trials Forecast by Phase (2022-2027)
9.3.2. Oncology Clinical Trials Market Share Forecast by Phase (2022-2027)
9.4. Oncology Clinical Trials Market Forecast by Applications (2022-2027)
9.4.1. Oncology Clinical Trials Forecast by Applications (2022-2027)
9.4.2. Oncology Clinical Trials Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Oncology Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Oncology Clinical Trials Revenue and Revenue Share by Phase (2017-2019)
Figure Global Phase I Revenue and Growth Rate (2017-2019)
Figure Global Phase II Revenue and Growth Rate (2017-2019)
Figure Global Phase III Revenue and Growth Rate (2017-2019)
Figure Global Phase IV Revenue and Growth Rate (2017-2019)
Table Global Oncology Clinical Trials Revenue and Revenue Share by Applications (2017-2019)
Figure Global Lung cancer Revenue and Growth Rate (2017-2019)
Figure Global Breast cancer Revenue and Growth Rate (2017-2019)
Figure Global Thyroid cancer Revenue and Growth Rate (2017-2019)
Figure Global leukemia Revenue and Growth Rate (2017-2019)
Figure Global Other Cancer Revenue and Growth Rate (2017-2019)
Table Global Oncology Clinical Trials Revenue by Regions (2017-2019)
Figure North America Oncology Clinical Trials Growth Rate (2017-2019)
Figure North America Oncology Clinical Trials Revenue and Growth Rate (2017-2019)
Figure North America Oncology Clinical Trials by Countries (2017-2019)
Figure North America Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure United States Oncology Clinical Trials Growth Rate (2017-2019)
Figure United States Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Oncology Clinical Trials Growth Rate (2017-2019)
Figure Canada Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Oncology Clinical Trials Growth Rate (2017-2019)
Figure Mexico Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Oncology Clinical Trials Growth Rate (2017-2019)
Figure Europe Oncology Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Europe Oncology Clinical Trials by Countries (2017-2019)
Figure Europe Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Germany Oncology Clinical Trials Growth Rate (2017-2019)
Figure Germany Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Oncology Clinical Trials Growth Rate (2017-2019)
Figure France Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Oncology Clinical Trials Growth Rate (2017-2019)
Figure UK Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Oncology Clinical Trials Growth Rate (2017-2019)
Figure Russia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Oncology Clinical Trials Growth Rate (2017-2019)
Figure Italy Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Oncology Clinical Trials Growth Rate (2017-2019)
Figure Rest of Europe Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Clinical Trials Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Clinical Trials by Countries (2017-2019)
Figure Asia-Pacific Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure China Oncology Clinical Trials Growth Rate (2017-2019)
Figure China Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Oncology Clinical Trials Growth Rate (2017-2019)
Figure Japan Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Oncology Clinical Trials Growth Rate (2017-2019)
Figure Korea Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Oncology Clinical Trials Growth Rate (2017-2019)
Figure India Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Oncology Clinical Trials Growth Rate (2017-2019)
Figure Southeast Asia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Clinical Trials Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Oncology Clinical Trials Growth Rate (2017-2019)
Figure South America Oncology Clinical Trials Revenue and Growth Rate (2017-2019)
Figure South America Oncology Clinical Trials by Countries (2017-2019)
Figure South America Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Oncology Clinical Trials Growth Rate (2017-2019)
Figure Brazil Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Oncology Clinical Trials Growth Rate (2017-2019)
Figure Argentina Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Oncology Clinical Trials Growth Rate (2017-2019)
Figure Columbia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Oncology Clinical Trials Growth Rate (2017-2019)
Figure Rest of South America Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Clinical Trials Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Clinical Trials by Countries (2017-2019)
Figure Middle East and Africa Oncology Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Oncology Clinical Trials Growth Rate (2017-2019)
Figure Saudi Arabia Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Clinical Trials Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Oncology Clinical Trials Growth Rate (2017-2019)
Figure Egypt Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Oncology Clinical Trials Growth Rate (2017-2019)
Figure Nigeria Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Oncology Clinical Trials Growth Rate (2017-2019)
Figure South Africa Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Oncology Clinical Trials Growth Rate (2017-2019)
Figure Turkey Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Clinical Trials Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Table PAREXEL International Corporation Oncology Clinical Trials Financial Overview
Table PRA Health Sciences Oncology Clinical Trials Financial Overview
Table Syneos Health Oncology Clinical Trials Financial Overview
Table Medpace Oncology Clinical Trials Financial Overview
Table Novotech Oncology Clinical Trials Financial Overview
Table Pivotal Oncology Clinical Trials Financial Overview
Figure Global Oncology Clinical Trials Revenue (Millions USD) and Growth Rate (2019-2027)
Table Oncology Clinical Trials Market Forecast by Regions (2019-2027)
Figure North America Oncology Clinical Trials Market Forecast (2019-2027)
Figure United States Oncology Clinical Trials Market Forecast (2019-2027)
Figure Canada Oncology Clinical Trials Market Forecast (2019-2027)
Figure Mexico Oncology Clinical Trials Market Forecast (2019-2027)
Figure Europe Oncology Clinical Trials Market Forecast (2019-2027)
Figure Germany Oncology Clinical Trials Market Forecast (2019-2027)
Figure France Oncology Clinical Trials Market Forecast (2019-2027)
Figure UK Oncology Clinical Trials Market Forecast (2019-2027)
Figure Russia Oncology Clinical Trials Market Forecast (2019-2027)
Figure Italy Oncology Clinical Trials Market Forecast (2019-2027)
Figure Rest of Europe Oncology Clinical Trials Market Forecast (2019-2027)
Figure Asia-Pacific Oncology Clinical Trials Market Forecast (2019-2027)
Figure China Oncology Clinical Trials Market Forecast (2019-2027)
Figure Japan Oncology Clinical Trials Market Forecast (2019-2027)
Figure Korea Oncology Clinical Trials Market Forecast (2019-2027)
Figure India Oncology Clinical Trials Market Forecast (2019-2027)
Figure Southeast Asia Oncology Clinical Trials Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Oncology Clinical Trials Market Forecast (2019-2027)
Figure South America Oncology Clinical Trials Market Forecast (2019-2027)
Figure Brazil Oncology Clinical Trials Market Forecast (2019-2027)
Figure Argentina Oncology Clinical Trials Market Forecast (2019-2027)
Figure Columbia Oncology Clinical Trials Market Forecast (2019-2027)
Figure Rest of South America Oncology Clinical Trials Market Forecast (2019-2027)
Figure Middle East and Africa Oncology Clinical Trials Market Forecast (2019-2027)
Figure Saudi Arabia Oncology Clinical Trials Market Forecast (2019-2027)
Figure United Arab Emirates Oncology Clinical Trials Market Forecast (2019-2027)
Figure Egypt Oncology Clinical Trials Market Forecast (2019-2027)
Figure Nigeria Oncology Clinical Trials Market Forecast (2019-2027)
Figure South Africa Oncology Clinical Trials Market Forecast (2019-2027)
Figure Turkey Oncology Clinical Trials Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Oncology Clinical Trials Market Forecast (2019-2027)
Figure Global Oncology Clinical Trials Forecast by Phase (2019-2027)
Figure Global Oncology Clinical Trials Market Share Forecast by Phase (2019-2027)
Figure Global Oncology Clinical Trials Forecast by Phase (2019-2027)
Figure Global Oncology Clinical Trials Forecast by Applications (2019-2027)
Figure Global Oncology Clinical Trials Market Share Forecast by Applications (2019-2027)
Figure Global Oncology Clinical Trials Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|